This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Gabriele Handke-Ergüden: Innovator in Pharmaceutical Chemistry
Introduction
Gabriele Handke-Ergüden is a notable inventor based in Wülfrath, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Handke-Ergüden holds a patent for "Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)." This patent relates to compounds of a specific formula, which are designed to treat ischaemia or reperfusion damage. The patent outlines methods for preparing these materials, as well as pharmaceutical compositions that incorporate them.
Career Highlights
He is currently employed at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on innovative solutions in drug development and therapeutic applications.
Collaborations
Throughout his career, Handke-Ergüden has collaborated with esteemed colleagues, including Barbara Albrecht and Michael Gerisch. These collaborations have further enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Gabriele Handke-Ergüden's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in advancing medical treatments. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile